Hiatal Hernia Market Summary
The Hiatal Hernia market size is anticipated to grow at a significant CAGR during the study period (2020–2034). Market growth is largely fueled by the increasing prevalence of hiatal hernias, advancements in surgical techniques, and rising demand for minimally invasive procedures, leading to improved patient outcomes and greater adoption of treatment options. Rising awareness among healthcare providers and patients, along with the development of innovative treatment options, is establishing hiatal hernia treatment as a key component of modern gastrointestinal care, accelerating the uptake of advanced therapies and boosting industry growth.
Explore DelveInsight’s Full Coverage on the Hiatal Hernia Market
Hiatal Hernia Overview
Hiatal hernia is a gastrointestinal condition that occurs when a portion of the stomach pushes upward through the diaphragm into the chest cavity via the esophageal hiatus. The diaphragm normally separates the chest from the abdomen and helps maintain correct positioning of abdominal organs. When the stomach protrudes through this opening, it can interfere with the normal function of the lower esophageal sphincter (LES), often leading to symptoms associated with acid reflux or gastroesophageal reflux disease (GERD).
Hiatal hernias are relatively common, particularly among older adults. In many cases, the condition may remain asymptomatic and be discovered incidentally during diagnostic procedures such as endoscopy or imaging studies. However, some individuals experience symptoms including heartburn, regurgitation, chest discomfort, difficulty swallowing, or chronic acid reflux.
There are two primary types: Sliding Hiatal Hernia, the most common form (accounting for the majority of cases), in which the stomach and the section of esophagus joining it slide upward through the diaphragm intermittently, often with reflux symptoms; and Paraesophageal Hiatal Hernia, a less common but potentially more serious form in which part of the stomach pushes through the diaphragm and sits beside the esophagus, which may lead to complications such as obstruction or strangulation.
Several factors can contribute to hiatal hernia development, including age-related weakening of the diaphragm muscles, increased abdominal pressure due to obesity, pregnancy, or heavy lifting, chronic coughing or straining during bowel movements, injury or trauma to the diaphragm, and congenital abnormalities affecting the diaphragm opening. Lifestyle factors such as smoking and poor dietary habits may also increase risk.
Hiatal Hernia Diagnosis and Treatment Algorithm
Diagnosis of hiatal hernia typically involves a combination of clinical evaluation and diagnostic procedures, including upper gastrointestinal endoscopy, barium swallow X-ray, esophageal manometry, and pH monitoring to evaluate acid reflux. These tests help physicians determine the presence, type, and severity of the hernia.
Treatment options depend on the severity of symptoms and the type of hernia. Many patients can manage symptoms through lifestyle changes and medications, including weight management, dietary modifications, avoiding large meals before bedtime, and elevating the head while sleeping. Medications such as proton pump inhibitors (PPIs), H2 receptor blockers, and antacids are commonly prescribed to control acid reflux symptoms. Surgery may be recommended for patients with severe symptoms, complications, or large paraesophageal hernias, with procedures such as laparoscopic fundoplication or hernia repair performed to restore the stomach to its proper position and strengthen the diaphragm opening.
Hiatal Hernia Market Players
Hiatal Hernia companies include: Medtronic Medical Device Business Services, Inc. BD W. L. Gore & Associates, Inc. Cook Integra LifeSciences Corporation AbbVie Baxter Getinge AB Olympus Corporation The Cooper Companies, Inc. Insightra Medical, Inc. Cousin Biotech Novus Scientific AB Tepha, Inc. Advanced Medical Solutions Group plc LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. University Surgical Associates Capital Surgeons Group And Others.
Hiatal Hernia Epidemiology
The Hiatal Hernia epidemiology section provides insights about the historical and current patient pool and forecasted trends for the seven major markets, covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034, along with key opinion leader views.
Key Findings: Prevalence increases with age, affecting 10% of those under 40 and up to 70% of those over 70 Type I (sliding) hernia is the most common, accounting for 83%–95% of cases, while Type II–IV (paraesophageal) hernias are less common but more severe
Hiatal Hernia Market Outlook
The Hiatal Hernia market is expected to witness steady growth in the coming years, driven by the rising prevalence of gastrointestinal disorders, increasing geriatric population, and advancements in minimally invasive surgical procedures. Improved diagnostic technologies, growing awareness, and expanding healthcare infrastructure are further anticipated to enhance treatment adoption and support market expansion globally. The Hiatal Hernia market size is estimated to reach USD XX million by 2034.
Among the factors contributing to this growth, rising prevalence of hiatal hernia and GERD, driven by lifestyle factors such as obesity, poor dietary habits, smoking, and sedentary lifestyles, is a major driver, as these factors increase abdominal pressure and weaken the diaphragm. The growing geriatric population, with older adults more susceptible to hiatal hernias due to weakened muscle tissues, is also significantly contributing to market expansion. Advancements in surgical techniques and medical devices, including minimally invasive laparoscopic and robotic-assisted surgeries as well as innovations in surgical mesh and graft materials, continue to improve treatment outcomes and adoption. Additionally, improved diagnostic technologies such as endoscopy, esophageal manometry, chest X-rays, and upper GI series are enabling earlier and more accurate detection, while rising awareness and healthcare expenditure, alongside the increasing adoption of minimally invasive procedures, are further propelling market growth.
Hiatal Hernia Drug Analysis
The drug chapter segment of the Hiatal Hernia market report encloses a detailed analysis of Hiatal Hernia marketed drugs and late-stage (Phase III and Phase II) pipeline drugs. It also helps in understanding the Hiatal Hernia clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest news and press releases.
Download the Hiatal Hernia market report for in-depth insights on pipeline and forecast
Conclusion
The Hiatal Hernia market is poised for steady growth through 2034, supported by the rising prevalence of gastrointestinal disorders, an expanding geriatric population, and continued advancements in surgical techniques and medical devices. While lifestyle and medical management remain the first line of care, growing adoption of minimally invasive and laparoscopic surgical approaches, coupled with improved diagnostic technologies, is expected to enhance patient outcomes. As awareness continues to rise and healthcare infrastructure expands, particularly in emerging economies, the Hiatal Hernia market is expected to witness continued transformation, creating new opportunities for stakeholders across the treatment landscape.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Us
Contact Person: Abhishek kumar
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com
